Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-04-02
1992-11-24
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549292, 560 17, 560 59, 562469, 562470, 514532, 514533, 514543, 514568, 514824, A61K 3137, C07D 3010
Patent
active
051661713
ABSTRACT:
6-Phenoxymethyl-4-hydroxytetrahydropyran-2-ones and 6-thiophenoxymethyl-4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, processes for the preparation of these compounds, their use as pharmaceuticals, pharmaceutical preparations and novel phenols and thiophenols Compounds of the general formula I ##STR1## and the corresponding open-chain dihydroxycarboxylic acids of the formula II ##STR2## in which X, Y and Z have the meanings given, and pharmacologically tolerated salts thereof with bases and pharmacologically tolerated esters thereof, processes for the preparation of these compounds, their use as pharmaceuticals and pharmaceutical preparations are described. Novel phenols and thiophenols of the formula III ##STR3## in which X, Y and Z have the meanings given, are also described.
REFERENCES:
patent: 4459422 (1984-07-01), Willard et al.
G. E. Stokker, et al., J. Med. Chem., "3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase Inhibitors," 28 (3), pp. 347-358, (1985).
Bartmann, W., Chemical Abstracts 109:128,826k, abstract of DE 3,632,893 A1, (1988).
Wess, G., et al., Derwent Abstract of EP 216,127 (1987).
G. E. Stokker et al., 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors 3, 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic Acids and Their Lactone J. Med. Chem. 1986, 29, 170-181.
G. E. Stokker et al., 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors, 5,6-(Fluoren-9-yl)- and 6-(Fluoren-9-ylodenyl)-3,5-dihydroxyhexanoic Acids and Their Lactone Derivatives, J. Med. Chem. 1986, 29, 852-855.
W. F. Hoffman et al., 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors, 2, Structural Modification of 7-(Substituted aryl)-3,5-dihydroxy-6-heptenoic Acids and Their Lactone Derivatives, J. Med. Chem. 1986, 29, 159-169.
N. Nakaya et al., The Effect of CS-514, an Inhibitor of HMG-CoA Reductase, on Serum Lipids in Healthy Volunteers Atherosclerosis, 1986, 61, 125-128.
Eptastatin Sodium, Drugs of the Future, 1987, 12, 437-442.
M. J. T. M. Mol et al., Effects of Synvinolin (MK-733) on Plasma Lipids in Familial Hypercholesterolaemia, The Lancet, Oct. 25, 1986, 936-939.
A. G. Olsson et al., Synvinolin in Hypercholesterolaemia Culture, The Lancet, Aug. 16, 1986, 390-391.
A. S. Pappu et al., Divergent Response of Plasma Mevalonate to Mevinlon Normal and Familial Hypercholesterolemic Subjects Clinical Research, 34, 1986, 684A.
Akira Endo, Compactin (ML-236B) and Related Compounds as Potential Cholesterol-Lowering Agents That Inhibit HMG-CoA Reductase, J. Med. Chem. 1985, 28, 401-405.
Bartmann Wilhelm
Beck Gerhard
Jendralla Heiner
Wess Gunther
Hoechst Aktiengesellschaft
Raymond Richard L.
Russell Mark W.
LandOfFree
6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones and 6-thiphenoxy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones and 6-thiphenoxy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones and 6-thiphenoxy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-921883